In metabolism studies in patients with SLE, the often-mentioned antibodies to cardiolipin (aCLs) and β2 glycoprotein1 (β2-GP1) are correlated with decreased HDL and ApoA1 (71). This evidence concerns the gene APOA1 and systemic lupus erythematosus.